Harvard Bioscience Q1 Adj $0.02, Inline, Sales $24.51M Miss $25.79M Estimate

Harvard Bioscience (NASDAQ:HBIO) reported quarterly earnings of $0.02 per share which met the analyst consensus estimate. This is a 66.67 percent decrease over earnings of $0.06 per share from the same period last year. The company reported quarterly sales of $24.51 million which missed the analyst consensus estimate of $25.79 million by 4.96 percent. This is a 18.23 percent decrease over sales of $29.98 million the same period last year.